 NEWTON, Mass., Dec. 22, 2021 GLOBE NEWSWIRE -- Acer Therapeutics Inc. Nasdaq: ACER, a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acers management team will participate in the upcoming 11th Annual LifeSci Partners Corporate Access virtual event and the H.C. Wainwright BioConnect Virtual Conference. 